Table 3 Clinical outcomes according to the dose of statin.

From: Postoperative statin treatment may be associated with improved mortality in patients with myocardial injury after noncardiac surgery

 Low to moderate (n = 1,143)High (n = 188)Unadjusted HR (95% CI)P value*Adjusted HR (95% CI)P value
One-year mortality68 (5.9)13 (6.9)1.18 (0.65–2.14)0.581.18 (0.64–2.19)0.59
Cardiovascular34 (3.0)9 (4.8)1.64 (0.79–3.42)0.191.49 (0.68–3.24)0.32
Noncardiovascular34 (3.0)4 (2.1)0.73 (0.26–2.04)0.541.30 (0.27–2.21)0.62
Overall mortality170 (14.9)29 (15.4)1.30 (0.87–1.93)0.21.41 (0.93–2.12)0.11
Cardiovascular99 (8.7)17 (9.0)1.35 (0.81–2.27)0.251.37 (0.79–2.35)0.26
Noncardiovascular71 (6.2)12 (6.4)1.23 (0.66–2.26)0.521.42 (0.75–2.68)0.28
  1. Data are presented as n (%) or mean (± standard deviation).
  2. *Covariates include age + male + diabetes + hypertension + smoking + smoking + ischemic heart disease + emergency operation + intraoperative red blood cell transfusion + in-hospital coronary revascularization + in-hospital ventilator care + in-hospital continuous renal replacement therapy + antiplatelet agent + beta blocker + calcium channel blocker + warfarin.